CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise | +9,467 | 1,288,912 | ||
| 2024-04-01 | Walker Neal INTERIM PRESIDENT AND CEO | Shares withheld for taxes | −3,224 | $1.26 | $4K | 1,285,688 |
| 2024-04-01 | Walker Neal INTERIM PRESIDENT AND CEO | Option exercise · Restricted Stock Units | −9,467 | 123,067 | ||
| 2024-03-04 | Powell Andrew Kenneth William Director | Purchase | +6,000 | $1.25 | $8K | 28,863 |
| 2024-03-02 | Monahan Joseph Chief Scientific Officer | Option exercise | +12,500 | 190,314 | ||
| 2024-03-02 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −3,531 | $1.24 | $4K | 186,783 |
| 2024-03-02 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −12,500 | 0 | ||
| 2024-03-02 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,500 | 24,410 | ||
| 2024-03-02 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −427 | $1.24 | $529 | 23,983 |
| 2024-03-02 | Balthaser Kevin Chief Financial Officer | Option exercise · Restricted Stock Units | −1,500 | 0 | ||
| 2024-03-01 | Walker Neal Interim President and CEO | Option exercise | +9,466 | 1,282,668 | ||
| 2024-03-01 | Walker Neal Interim President and CEO | Shares withheld for taxes | −3,223 | $1.24 | $4K | 1,279,445 |
| 2024-03-01 | Walker Neal Interim President and CEO | Option exercise · Restricted Stock Units | −9,466 | 132,534 | ||
| 2024-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +50,000 | 184,641 | ||
| 2024-03-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −14,569 | $1.24 | $18K | 170,072 |
| 2024-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise | +10,925 | 180,997 | ||
| 2024-03-01 | Monahan Joseph Chief Scientific Officer | Shares withheld for taxes | −3,183 | $1.24 | $4K | 177,814 |
| 2024-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −50,000 | 50,000 | ||
| 2024-03-01 | Monahan Joseph Chief Scientific Officer | Option exercise · Restricted Stock Units | −10,925 | 21,850 | ||
| 2024-03-01 | Balthaser Kevin Chief Financial Officer | Option exercise | +1,100 | 21,525 |
Page 15 of 34 · 680 trades